Transdermal Drug Delivery System Market and its Growth Prospect in the Near Future

auteur de l'information

Pramod Kumar has 59 Published Articles

India,
Uttar Pradesh,
Noida,
Block-13, Sector 2, Noida, Uttar Pradesh - 201301 India,

Transdermal Drug Delivery System Market and its Growth Prospect in the Near Future

Posté le: Dec-18-2019 | vue (518) fois | Word Count article: 552 |

The transdermal drug delivery systems market valued over $30.0 billion in 2016, and it is predicted to grow significantly, with a CAGR of around 10.0%, during 2017–2023 (forecast period).

The transdermal drug delivery systems market valued over $30.0 billion in 2016, and it is predicted to grow significantly, with a CAGR of around 10.0%, during 2017–2023 (forecast period).
The growth of the market is attributed to the surging geriatric population, rising prevalence of chronic diseases, and increasing adoption of advanced systems. The term, transdermal drug delivery systems, refers to an advanced mode of medication that delivers drugs directly into the blood stream through the skin.
When type is taken into consideration, the transdermal drug delivery systems market is divided into passive and active systems. The passive division held the larger share of the market in 2016. This type is preferred by patients as it is painless and also convenient to use. The division is further bifurcated into matrix and reservoir systems, wherein matrix systems held the larger share of the market in 2016 and are expected to dominate the market during the forecast period as well.
On the basis of application, the transdermal drug delivery systems market is categorized into hormone replacement therapy, motion sickness, analgesics, hypertension, smoking cessation, and others. Analgesics led the market in 2016, generating a revenue of about $10.0 billion. The category is further expected to retain its position in the market during the forecast period, growing with a CAGR of 9.6%. The hypertension category is also predicted to grow considerably, thereby becoming a significant factor for the rapid growth of the market.
Request to Get the Sample Pages at: https://psmarketresearch.com/market-analysis/transdermal-drug-delivery-systems-market/report-sample
The rising prevalence of chronic diseases is one of the major reasons for the growth of the transdermal drug delivery systems market. According to the Centers for Disease Control and Prevention (CDC), one in every three adults in the U.S. has high blood pressure. Other than this, the World Health Organization (WHO) stated that in 2015, over 1.1 billion people smoked tobacco, which leads to respiratory diseases, such as lung cancer and chronic obstructive pulmonary disease. Due to these factors, the demand for transdermal drug delivery systems is increasing globally.
Another factor driving the growth of the transdermal drug delivery systems market is the technological advancements in the field. In order to administer small as well as large-molecule drugs in the bloodstream, second and third-generation delivery systems have been introduced in the market. While first-generation systems release drugs across the skin without the use of external force, second-generation systems use driving forces for transportation of small-molecule drugs. Third-generation systems target the penetration of the stratum corneum, while protecting the deeper tissues, for transferring small-molecule and macromolecule drugs.

Healthcare systems in emerging economies are undergoing rapid changes, which, in turn, provides an opportunity to the players looking at investing in the transdermal drug delivery systems market. The increasing need for adequate healthcare facilities, rising geriatric population, and growing prevalence of chronic diseases are predicted to drive the demand for drug patches during the forecast period. In January 2014, the World Economic Forum stated in its paper, Health Systems Leapfrogging in Emerging Economies, that due to the economic growth in India and China, healthcare spending is projected to continue increasing.

Hence, technological advancements in transdermal drug delivery systems, rising prevalence of chronic diseases, and increasing investments in the healthcare sector in developing nations are driving the growth of the market.

Re-publier cet article

<h1>Transdermal Drug Delivery System Market and its Growth Prospect in the Near Future</h1> Author: <a href='http://fr.articleseen.com/profile_Pramod Kumar.aspx'>Pramod Kumar</a> The transdermal drug delivery systems market valued over $30.0 billion in 2016, and it is predicted to grow significantly, with a CAGR of around 10.0%, during 2017–2023 (forecast period). 
The growth of the market is attributed to the surging geriatric population, rising prevalence of chronic diseases, and increasing adoption of advanced systems. The term, transdermal drug delivery systems, refers to an advanced mode of medication that delivers drugs directly into the blood stream through the skin.
When type is taken into consideration, the transdermal drug delivery systems market is divided into passive and active systems. The passive division held the larger share of the market in 2016. This type is preferred by patients as it is painless and also convenient to use. The division is further bifurcated into matrix and reservoir systems, wherein matrix systems held the larger share of the market in 2016 and are expected to dominate the market during the forecast period as well. 
On the basis of application, the transdermal drug delivery systems market is categorized into hormone replacement therapy, motion sickness, analgesics, hypertension, smoking cessation, and others. Analgesics led the market in 2016, generating a revenue of about $10.0 billion. The category is further expected to retain its position in the market during the forecast period, growing with a CAGR of 9.6%. The hypertension category is also predicted to grow considerably, thereby becoming a significant factor for the rapid growth of the market.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/transdermal-drug-delivery-systems-market/report-sample
The rising prevalence of chronic diseases is one of the major reasons for the growth of the transdermal drug delivery systems market. According to the Centers for Disease Control and Prevention (CDC), one in every three adults in the U.S. has high blood pressure. Other than this, the World Health Organization (WHO) stated that in 2015, over 1.1 billion people smoked tobacco, which leads to respiratory diseases, such as lung cancer and chronic obstructive pulmonary disease. Due to these factors, the demand for transdermal drug delivery systems is increasing globally. 
Another factor driving the growth of the transdermal drug delivery systems market is the technological advancements in the field. In order to administer small as well as large-molecule drugs in the bloodstream, second and third-generation delivery systems have been introduced in the market. While first-generation systems release drugs across the skin without the use of external force, second-generation systems use driving forces for transportation of small-molecule drugs. Third-generation systems target the penetration of the stratum corneum, while protecting the deeper tissues, for transferring small-molecule and macromolecule drugs.

Healthcare systems in emerging economies are undergoing rapid changes, which, in turn, provides an opportunity to the players looking at investing in the transdermal drug delivery systems market. The increasing need for adequate healthcare facilities, rising geriatric population, and growing prevalence of chronic diseases are predicted to drive the demand for drug patches during the forecast period. In January 2014, the World Economic Forum stated in its paper, Health Systems Leapfrogging in Emerging Economies, that due to the economic growth in India and China, healthcare spending is projected to continue increasing.

Hence, technological advancements in transdermal drug delivery systems, rising prevalence of chronic diseases, and increasing investments in the healthcare sector in developing nations are driving the growth of the market.
About the Author: P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. Article Source: <a href='http://fr.articleseen.com/Article_Transdermal-Drug-Delivery-System-Market-and-its-Growth-Prospect-in-the-Near-Future_988.aspx'> http://fr.articleseen.com/Article_Transdermal Drug Delivery System Market and its Growth Prospect in the Near Future_988.aspx</a>

Source de l'article : http://fr.articleseen.com/Article_Transdermal Drug Delivery System Market and its Growth Prospect in the Near Future_988.aspx

auteur ressource :
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Mots-clés : Transdermal Drug Delivery System Market,

Catégorie : Santé et Fitness : Santé et Fitness

Print this Article Send to Friend